Genetic Health Risk reports are intended to provide you with genetic information to inform conversations with a healthcare professional.
23andMe won a landmark FDA authorization last year to market DTC
genetic health risk reports for 10 conditions, including Alzheimer's and Parkinson's.
Not exact matches
The Alphabet - backed Silicon Valley startup, valued at $ 1.1 billion, became the first company allowed to sell
genetic tests (and accompanying
health -
risk reports) for 10 different diseases directly to consumers without a prescription.
The $ 1.1 billion Alphabet - backed Silicon Valley unicorn 23andMe just pulled off a milestone feat: On Thursday, the Food and Drug Administration (FDA) said the company could sell its
genetic tests and accompanying
health risk reports for ten different diseases directly to consumers.
Named for the 23 pairs of chromosomes that make up humankind, this company — which touts its «FDA standards for clinical and scientific validity» — offers
genetic health risk and carrier status
reports, gives ancestry percentages down to 0.1 percent, and the opt - in ability to join the DNA Relative Finder.
23andme further offers a
report on your
genetic health risks, including whether you have
genetic mutations for diseases like cystic fibrosis that may affect any future children and how likely you are to develop Parkinson's or Alzheimer's.
Learn more about
Genetic Health Risks and Carrier Status reports, genetic counseling and what to know about test r
Genetic Health Risks and Carrier Status
reports,
genetic counseling and what to know about test r
genetic counseling and what to know about test results.
The DNA
report would contain important information such as ancestral breed breakdown percentages of your dog and
risks for developing
genetic health diseases.
«The Canine Lifetime
Health Project is a groundbreaking, long - term effort to identify
genetic, nutritional and environmental
risk factors for the development of cancer and other canine diseases,» MAF
reports.